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N-methyl-d-aspartate (nmDA) receptors belong to the family of ionotropic glutamate receptors 
that mediate a majority of excitatory synaptic transmission. one unique property of Glun1/
Glun2D nmDA receptors is an unusually prolonged deactivation time course following the 
removal of l-glutamate. Here we show, using x-ray crystallography and electrophysiology, that 
the deactivation time course of Glun1/Glun2D receptors is influenced by the conformational 
variability of the ligand-binding domain (LBD) as well as the structure of the activating ligand. 
l-glutamate and l-CCG-IV induce significantly slower deactivation time courses compared 
with other agonists. Crystal structures of the isolated Glun2D LBD in complex with various 
ligands reveal that the binding of l-glutamate induces a unique conformation at the backside of 
the ligand-binding site in proximity to the region at which the transmembrane domain would 
be located in the intact receptors. These data suggest that the activity of the Glun1/Glun2D 
nmDA receptor is controlled distinctively by the endogenous neurotransmitter l-glutamate. 
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A majority of communication between neurons is mediated by release and reception of neurotransmitters at the synapse. On binding to neurotransmitters, ligand-gated ion channels 
generate postsynaptic currents that serve as neuronal signals. This 
neurotransmission dictates the strength of neuronal interactions, 
and is a major currency for brain development and function. In the 
mammalian brain, the strength and time course of l-glutamate-
mediated excitatory postsynaptic currents are determined by the 
functional properties of ionotropic glutamate receptors (iGluRs), 
which can be classified into three pharmacological and gene fami-
lies, including α-amino-3-hydroxy-5-methyl-4-propionic acid 
(AMPA), kainate and N-methyl-d-aspartate (NMDA) receptors1,2. 
NMDA receptors deactivate significantly more slowly than non-
NMDA receptors, thus comprising the slow component of excita-
tory postsynaptic signals3,4.
NMDA receptors are tetrameric ion channels composed of two 
GluN1 subunits and two GluN2 subunits, and are unique among the 
iGluR family members in that activation requires concurrent bind-
ing of glycine and l-glutamate to the GluN1 and GluN2 subunits, 
respectively1,2. NMDA receptor subunits possess a modular design 
and are composed of an amino-terminal domain (ATD), a ligand-
binding domain (LBD), a transmembrane domain that forms the ion 
channel pore and an intracellular carboxyl-terminal domain. The 
recent crystallographic study on the full-length homomeric GluA2 
receptor has revealed the overall architecture of domain organiza-
tion of a tetrameric subunit arrangement for AMPA receptors5. 
In contrast, structure–function studies of NMDA receptors have 
lagged behind AMPA receptors, primarily because of experimental 
complexities stemming from the heteromeric assembly of the GluN1 
and GluN2 subunits. Nevertheless, structural insights into NMDA 
receptor function have been gained through recent crystallographic 
studies on the LBDs6–9. The most extensive studies have been con-
ducted on the LBDs of the GluN1/GluN2A7 and the GluN3A and 
GluN3B subunits9, revealing a bilobed clamshell-like architecture 
composed of domain-1 (D1) and domain-2 (D2), with a ligand- 
binding pocket at the D1–D2 cleft, similar to the structure of the non-
NMDA receptor LBDs6–8. However, there are substantial differences 
in how conformational changes couple to gating of the ion channels 
between AMPA and NMDA receptors, indicating that the physico-
chemical properties of the LBDs may depend on the subunit10.
The four distinct GluN2 subunits (GluN2A–GluN2D) provide 
the functional and pharmacological diversity of NMDA receptors, 
including differences in potency and deactivation time course1,11. 
NMDA receptors that contain the GluN2D subunit have ~ 40-fold 
longer deactivation time course compared with receptors contain-
ing GluN2A12,13. The unique properties of the GluN2D-containing 
NMDA receptors are considered important both for early brain 
development as well as function of neurons specifically expressing 
the GluN2D subunits in the mature brain14–16.
Several lines of investigation have identified factors that regulate 
deactivation time course in NMDA receptors. For example, some 
studies have suggested that the ligand association and dissociation 
rates at the LBDs are the primary determinants of the deactivation 
time course of neuronal and GluN2A-containing NMDA receptors, 
as well as AMPA and kainate receptors7,17–19. Furthermore, recent 
studies have shown that the GluN2 ATD and a linker between the 
ATD and the LBD (ATD–D1 linker) influence deactivation time 
course20,21, indicating that the ATD exerts significant control over 
deactivation. Previous single-channel studies have shown that the 
deactivation time course of macroscopic currents of NMDA recep-
tors is dependent on channel burst length4, which has been shown 
to depend on a series of rate constants that describe NMDA recep-
tor gating and differ according to the type of GluN2 subunit present 
in the receptor13,21–23.
In this study, we measure the deactivation time course of recom-
binant GluN1/GluN2D receptor currents induced by a range of 
agonists. The data show that l-glutamate elicits a much slower deac-
tivation time course compared with other excitatory amino acids. 
Crystallographic studies of the isolated GluN2D LBD monomer 
show a unique conformation around the hinge and D2 domains 
of the bilobed clamshell when complexed with l-glutamate com-
pared with other ligands. Moreover, structure-based mutagenesis 
suggests that the differences in amino acids between the GluN2A 
and GluN2D LBDs may distinctively influence the time course 
of deactivation. These data are consistent with the idea that the 
unique conformation of the l-glutamate-bound LBD may underlie 
the unusually slow deactivation time course for l-glutamate in the 
GluN1/GluN2D receptors.
Results
Linear non-l-glutamate agonists evoke rapid GluN2D deacti-
vation. To assess the dependence of the deactivation time course 
of GluN1/GluN2D NMDA receptors on the structure of acti-
vating ligands, we recorded whole-cell responses under voltage 
clamp from HEK cells expressing recombinant GluN1/GluN2D 
and compared the response time courses of a series of glutamate 
and aspartate analogues. The coagonist glycine was present in all 
solutions (0.05 mM), and current responses were evoked with a 1-s 
pulse of 1-mM agonist. Following a 1-s pulse of 1-mM l-glutamate, 
the GluN1/GluN2D receptors deactivated slowly with a dual 
exponential time course with time constants of τFast = 930 ± 100 ms 
and τSlow = 3,200 ± 240 ms (n = 30; Fig. 1a; Table 1), as previously 
described12,13,21. Interestingly, the stereoisomer d-glutamate caused 
the receptor to deactivate much more rapidly, with time constants of 
τFast = 27 ± 2.4 ms and τSlow = 440 ± 120 ms (n = 12; Fig. 1a; Table 1).
We subsequently assessed deactivation time course for other 
agonists. The glutamate analogue l-homocysteate, which has 
been detected in the brain and may function as an endogenous 
neurotransmitter24–27, also caused the GluN1/GluN2D receptor to 
deactivate much more rapidly than l-glutamate (Table 1). l-aspar-
tate (τFast = 130 ± 10 ms; τSlow = 280 ± 25 ms; n = 8) and d-aspartate 
(τFast = 99 ± 8.3 ms; τSlow = 460 ± 100 ms; n = 7) had similar deacti-
vation time constants, both of which are faster than l-glutamate 
(Fig. 1a; Table 1). This suggests that any GluN2D-containing 
NMDA receptor at synapses at which aspartate participates as a 
primary neurotransmitter may deactivate more rapidly than 
synapses at which l-glutamate is released28–32.
Cyclic agonists evoke slow GluN2D deactivation. Several com-
pounds with conformationally constrained rings function as partial 
agonists of NMDA receptors (Table 1, Supplementary Table S1), in 
some cases with higher potency (that is, lower half maximal effec-
tive concentration, or EC50) compared with l-glutamate33. We tested 
whether these compounds could evoke a slower deactivation time 
course than l-glutamate (Fig. 1b). Agonists (plus 0.05-mM glycine) 
were applied for 1 s at concentrations of 0.1–1 mM to HEK cells 
expressing GluN1/GluN2D. The most potent cyclic ligand l-CCG-
IV, with an EC50 value (36 nM) that was tenfold lower than l-gluta-
mate, deactivated with a time course that was significantly different 
(P < 0.05; analysis of variance (ANOVA)) from all ligands except 
l-glutamate (τFast = 1,200 ± 290 ms and τSlow = 3,200 ± 600 ms). trans-
ACBD, with a similar potency to l-glutamate, deactivated signifi-
cantly faster than l-glutamate, with time constants of τFast = 280 ± 69 ms 
and τSlow = 1,300 ± 320 ms (n = 5; Fig. 1b, Table 1; ANOVA).
Relationship of GluN1/GluN2D deactivation and agonist 
potency. Previous studies have demonstrated that the deactivation 
time course is correlated with the ligand EC50 for AMPA receptors34. 
Figure 2a shows the relationship between experimentally deter-
mined EC50 and τSlow for GluN1/GluN2D receptors activated by 
linear ligands for which τSlow accounted for  > 10% of the deactiva-
tion time course. Although it would be informative to evaluate the 
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relationship between deactivation, agonist EC50 and agonist dissoci-
ation rate using models of NMDA receptor gating, a kinetic scheme 
that can reproduce the low open probability, rapid rise time, slow 
deactivation, absence of desensitization, high glutamate potency 
and single-channel properties of GluN1/GluN2D is not available. 
We therefore utilized modified models of GluN1/GluN2A, GluN1/
GluN2B and GluN1/GluN2C receptor function in which desensi-
tization steps were removed and binding states were altered23,35,36 
to explore the relationship between -deactivation and EC50 values 
as the dissociation rate varied (see Methods and Supplementary 
Fig. S1). Whereas these adapted models only approximately predict 
the properties of GluN1/GluN2D they nevertheless provide insight 
into the relationship between the time course for deactivation and 
the EC50 value for NMDA receptors as the glutamate dissociation 
rate is varied. Figure 2a shows that this relationship for glutamate 
superimposed on experimentally determined τSlow and EC50 for lin-
ear agonists that have a sufficiently large slow component ( > 10%) 
of deactivation that allows reliable determinations of τSlow. Although 
gating rates almost certainly vary among ligands, these measured 
parameters lie close to the predicted curve for l-glutamate. How-
ever, these models do not predict measured response properties of 
cyclic ligands, which have fewer conformational degrees of freedom 
than linear agonists and the actions of which may be described by 
rates that differ substantially from l-glutamate (Fig. 2b). Whereas 
these data show how the experimentally determined τSlow relates to 
the EC50 for linear ligands activating GluN1/GluN2D receptors, the 
adapted models do not predict a fast component of deactivation 
comparable to that determined experimentally for GluN1/GluN2D 
receptors. At present, factors that control the magnitude or relative 
contribution of the faster time constant describing the deactivation 
time course of GluN1/GluN2D receptors remain unknown.
GluN1/GluN2D deactivation is not influenced by desensitiza-
tion. Previous studies have demonstrated that even brief pulses 
of agonist can induce some desensitization of GluN1/GluN2A 
NMDA receptors37. We cannot detect any desensitization of GluN1/
GluN2D macroscopic current response in whole-cell recordings. 
Nevertheless, we used a paired-pulse paradigm on excised patches 
containing GluN1/GluN2D receptors to evaluate whether some 
receptors might enter a desensitized state from which they recover 
during deactivation. The peak current amplitude and deactiva-
tion time course of GluN1/GluN2D receptors seem to be uninflu-
enced by desensitization using a paired-pulse protocol following 
a 2-ms or 4-s application of 1-mM l-glutamate and 0.05-mM gly-
cine to excised outside-out patches (n = 8; Supplementary Fig. S2). 
Whereas it is possible that the receptor desensitizes more rapidly 
than can be detected (that is, within a few microseconds), we do not 
observe any effect of desensitization on the deactivation time course 
(Supplementary Fig. S2).
Crystal structures of GluN2D LBD. To evaluate the idea that 
GluN2D may adopt unique agonist-dependent conformations 
that influence the deactivation time course, we used X-ray crys-
tallography to explore the structures of the isolated GluN2D LBD 
monomer in complex with four agonists: l-glutamate, d-glutamate, 
l-aspartate and NMDA. The crystals showed X-ray diffractions 
higher than 1.9 Å (Supplementary Table S2), which resulted in 
structures with unambiguous electron densities for proteins, ligands 
and water molecules.
The GluN2D LBD has a bilobed clamshell-like architecture com-
posed of domains D1 and D2 (Fig. 3a,b), similar to that observed 
in the previously solved GluN2A LBD structure7. The GluN2A and 
GluN2D structures in complex with l-glutamate can be superim-
posed to one another with root mean square deviation of 0.88 Å 
over 240 out of 285 possible Cα positions (Fig. 3c). However, there 
are two regions in the clamshell structures that are distinct from 
one another: the conformation of the loop at the backside of the 
ligand-binding site (‘hinge loop’; Fig. 3c), and loop-1 tethered to 
the protein core by two disulphide bonds in domain D1 (Fig. 3a, 
Supplementary Fig. S3). Interestingly, the structures of GluN2D in 
complex with NMDA, l-aspartate and d-glutamate show similar-
ity to GluN2A at the hinge loop (Fig. 3d), raising the possibility 
that ligands that show rapid deactivation from GluN2D produce a 
conformation similar to that of GluN2A.
A striking feature of the GluN2D LBD structures in complex 
with various ligands is the considerable difference in the conforma-
tion of the ‘hinge loop’ between the l-glutamate-bound form and 
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Figure 1 | Deactivation time course is dependent on ligand structure. 
HEK cells were activated under voltage clamp by maximally effective 
concentrations of various linear agonists (a; l-glutamate, d-glutamate,  
l-aspartate and d-aspartate) and cyclic agonists (b; l-CCG-IV, trans-ACBD, 
(RS)-(tetrazol-5-yl)glycine and cis-ACPD) applied for 1 s; all solutions 
contained 0.05-mm glycine. l-glutamate and l-CCG-IV evoked the slowest 
deactivation time courses of the ligands examined. All other linear and 
cyclic agonists evoked significantly more rapid deactivation time courses 
compared with l-glutamate or l-CCG-IV. The deactivation time constants 
are given as the mean of 5–26 cells.
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all the other forms (Fig. 4a). The loop spans eight residues from 
Ile775 to Ala782, with a large difference in Cα positions ranging 
from ~1.4 to 9.8 Å between the l-glutamate-bound structures and 
the other three structures (Fig. 4). The hinge loops in the l-aspar-
tate-, d-glutamate- and NMDA-bound structures have similar con-
formations and interact with a structural motif containing helix-E 
and -F through hydrophobic interactions involving Tyr723, Val780 
and Phe781 (Fig. 4d). This particular orientation of the hinge loop 
stabilizes the interaction with the structural motif containing helix-
D and loop-D, which is located in proximity to the Gly–Thr linker, 
through hydrophobic interactions mediated by a cluster of nonpo-
lar residues, including Ile558, Leu690, Val780 and Phe781 (Fig. 4d). 
All of the above interactions tie the hinge loop, helix-E and -F, 
and helix-D and loop-D into one unit (Fig. 4d). In contrast, in the 
l-glutamate-bound structure, these interactions are absent because 
of a large conformational difference in the hinge loop; instead of 
helix-E and -F, the hinge loop is tied to helix-H through a nonpolar 
interaction between Val780 and Ala757 (Fig. 4e). Furthermore, in 
the l-glutamate-bound structure, helix-D and loop-D are disor-
dered, likely, because the hinge loop in the l-glutamate-bound con-
formation may not be suitable to form an interaction with loop-D 
and may not be able to lock the conformation of loop-D.
The local conformational change described above is unlikely 
to reflect crystallographic artefacts for two reasons. First, all of the 
crystals in complex with four ligands have been grown in the same 
condition and are isomorphous to each other; therefore, no chemi-
cal factor favours one conformation over another. Second, no crystal 
contact forces the hinge loop, helix-D, -E and -F, and loop-D into the 
observed conformations. Thus, the crystal packing around the region is 
sufficiently ‘loose’ to allow conformational change within the crystal 
lattice. Finally, soaking the GluN2D LBD-l-aspartate crystals against 
a buffer containing l-glutamate can change the hinge conformation to 
that observed in the GluN2D LBD-l-glutamate cocrystal structure.
The current study is the first that structurally shows the bind-
ing pattern of NMDA to GluN2 receptors. Therefore, the molecu-
lar determinants defining the selectivity for the agonist NMDA can 
now be visualized (Fig. 5). Electron density for all ligands, situated 
at the clamshell cleft between D1 and D2, is visible owing to the 
high-resolution X-ray diffraction data (Fig. 5a–d). The ligands tested 
in this study bind to GluN2D through direct polar interactions 
involving the main-chain oxygens and nitrogens of Ser536, Thr538, 
Arg543, Ser714 and Thr715, which are conserved in the binding 
of l-glutamate to GluN2A7. In addition to the polar interactions, 
the binding of NMDA involves displacement of a water molecule 
(W in Fig. 5a–d) by the N-methyl group, the placement of which 
is favoured by the surrounding hydrophobic residues, Tyr755 and 
Val759. The equivalent residues for Tyr755 in AMPA and kainate 
receptors are leucine and methionine, respectively, pointing away 
from the binding pocket (Fig. 5e). The corresponding residues for 
Val759 are methionine in AMPA receptors and threonine in kain-
ate receptors, which are more hydrophilic (Fig. 5e). Furthermore, 
Asp756 folds away from the binding pocket so that its β-carboxyl 
group does not interfere with the placement of the N-methyl group 
of NMDA. The aspartate residue at the 756 position is conserved 
among the subunits of NMDA receptors. In non-NMDA receptors, 
the equivalent residue of Asp756 is glutamate, the longer side chain 
of which would collide with the N-methyl group and disallow the 
placement of an NMDA molecule in their binding pockets.
Table 1 | Deactivation time course of GluN2D- and GluN2A-containing receptors.
Ligand Fast (ms) Slow (ms) W (ms) Fast (%) n EC50 (M)
GluN1/GluN2D
 l-glutamate 930 ± 100 3200 ± 240. 2300 ± 96 37 ± 4.3 30 0.48
 d-glutamate 27 ± 2.4* 440 ± 120* 42 ± 4.8* 93 ± 2.4* 12 42
 l-aspartate 130 ± 10* 280 ± 25* 160 ± 4.5* 74 ± 7.9* 8 5.0
 d-aspartate 99 ± 8.3* 460 ± 100* 130 ± 13* 90 ± 1.5* 7 2.1
 N-methyl-l-aspartate 17 ± 4.5* 91 ± 18* 38 ± 2.5* 62 ± 11 6 40
 N-methyl-d-aspartate 60 ± 2.2* 280 ± 36* 75 ± 3.4* 93 ± 1.9* 5 7.3
 l-homocysteate 160 ± 27* 540 ± 59* 370 ± 23* 43 ± 9.7 5 3.4
 d-homocysteate 35 ± 2.9* 300 ± 97* 45 ± 3.2* 91 ± 4.0* 10 22
 (2S,4R)-4-methylglutamate (sYm 2081) 130 ± 32* 520 ± 76* 330 ± 47* 48 ± 9.5 5 3.2
 (2S,4S)-4-methylglutamate 25 ± 5.0* 190 ± 59* 56 ± 10* 66 ± 15 5 31
 l-CCG-IV 1200 ± 290 3200 ± 600 2500 ± 370 32 ± 4.5 5 0.036
 (RS)-(tetrazol-5-yl)glycine 600 ± 140 2100 ± 340 1400 ± 190* 42 ± 12 5 0.099
 trans-ACBD 280 ± 69* 1300 ± 320* 620 ± 77* 59 ± 10 5 0.51
 cis-ACPD 120 ± 23* 940 ± 190* 350 ± 88* 72 ± 11 5 11
GluN1/GluN2A
 l-glutamate 38 ± 1.7 330 ± 50 54 ± 3.2 88 ± 4.0 21 4.5
 d-glutamate 16 ± 1.3** 280 ± 130 22 ± 3.0** 95 ± 1.9 7 250
 l-aspartate 20 ± 2.5** 340 ± 72 32 ± 6.1** 96 ± 1.4 7 48
 d-aspartate 26 ± 3.3 810 ± 540 35 ± 6.5 83 ± 9.2 6 30
 N-methyl-l-aspartate 9.5 ± 1.4** 170 ± 130 11 ± 1.3** 96 ± 3.0 6 580
 N-methyl-d-aspartate 16 ± 1.8** 320 ± 58 20 ± 2.1** 98 ± 1.4 4 94
 l-homocysteate 15 ± 3.5** 430 ± 190 31 ± 6.9 80 ± 17 5 34
 d-homocysteate 15 ± 3.0** 290 ± 16 22 ± 3.1** 98 ± 0.22 4 180
 (2S,4R)-4-methylglutamate (sYm 2081) 39 ± 4.2 350 ± 49 52 ± 5.6 95 ± 18 5 144
 (2S,4S)-4-methylglutamate 11 ± 1.0** 47 ± 15 13 ± 1.2** 93 ± 3.9 5 404
 l-CCG-IV 54 ± 7.2** 240 ± 43 70 ± 8.4 89 ± 5.8 5 0.26
 (RS)-(tetrazol-5-yl)glycine 60 ± 8.2** 300 ± 58 89 ± 9.0** 84 ± 6.8 5 1.7
 trans-ACBD 40 ± 5.4 420 ± 77 59 ± 6.0 96 ± 0.98 5 3.1
 cis-ACPD 39 ± 4.2 350 ± 49 52 ± 5.6 95 ± 1.9 5 61
τFast, τSlow, τW and fast (%) values are shown as mean ± s.e.m., and n is the number of cells. Values are given to two significant figures. All EC50 values except l-glutamate and l-aspartate are from Erreger 
et al. (2007)33. *P < 0.05 compared with the deactivation time course of Glun1/Glun2D activated by l-glutamate; one-way analysis of variance (AnoVA) with Tukey’s post hoc test. **P < 0.05 when 
compared with the deactivation time course of Glun1/Glun2A activated by l-glutamate and analyzed by one-way AnoVA with Tukey’s post hoc test.
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Molecular correlates of GluN1/GluN2D deactivation time 
course. Our data demonstrate that the deactivation time course 
of the GluN1/GluN2D receptors differs markedly between cur-
rents evoked by l-glutamate and other linear agonists. Surprisingly, 
the ligand dependence on the relative amplitudes of the two time 
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Figure 2 | The relationship between deactivation and EC50. (a) The 
relationship between the experimentally determined τslow and the EC50 
value for the steady-state response is shown for linear ligands for which 
τslow contributes >10% to the deactivation time course (l-glutamate, 
l-homocysteate, l-aspartate, nmLA, (2S,4R)-4-methylglutamate and 
(2S,4S)-4-methylglutamate). superimposed on these data are simulated 
response properties from modified nmDA receptor-gating models 
for Glun1/Glun2A, Glun1/Glun2B and Glun1/Glun2C23,35,36 adapted 
for l-glutamate-activated Glun1/Glun2D receptors by removal of the 
desensitized states (see methods and supplementary Fig. s1). We first 
determined association and dissociation rate constants that yielded a 
steady-state EC50 and deactivation time constant similar to that measured 
for l-glutamate-activated Glun1/Glun2D. We subsequently simulated 
the responses of each adapted model using an association rate (b + ) of 
1.0×106 m − 1 s − 1. The dissociation rates (b − ) were varied between 0.1 and 
100 s − 1, while holding the gating rates constant. The solid lines show the 
relationship between the EC50 value and τ-deactivation for each adapted 
model. (b) The relationship between experimentally determined EC50 
values and τslow for the cyclic ligands is shown. superimposed on this plot  
is the relationship between τ-deactivation and the EC50 value 
predicted for l-glutamate activation of the Glun1/Glun2A-adapted 
model as dissociation rates vary between 0.5 and 100 s − 1 (solid line). 
simulations using the same rate constants and a faster association rate 
(1.0×107 m − 1 s − 1) are shown (broken line; gating rates held constant). The 
faster association rates provided a better prediction of the τslow of l-CCG-IV 
and (RS)-(tetrazol-5-yl)glycine, but did not predict the deactivation time 
courses of trans-ACBD and cis-ACPC. 
Figure 3 | Crystal structure of GluN2D LBD. (a, b) overall structure of the 
bilobed Glun2D LBD in complex with nmDA (green sticks) is shown with 
the n terminus (nT) and C terminus (CT) on top and bottom, respectively. 
Ligands such as nmDA bind to the interdomain cleft between domain 1 
(D1; wheat) and domain 2 (D2; light grey). Three disulphide bonds (a–c; 
cyan sticks) are formed between the following cysteine pairs: Cys452 
and Cys490 (a), Cys459 and Cys481 (b), and Cys770 and Cys825 
(c). The sphere indicated as ‘linker’ is the Cα of glycine in the Gly and 
Thr residues that replace the transmembrane domains. (c) structural 
comparison between l-glutamate bound to Glun2D (wheat and light grey) 
and Glun2A (PDB code: 2A5s, green) in stereoview. The superposition 
shows the divergent region, the hinge loop (green arrow: Glun2A and 
grey arrow: Glun2D), proximal to helices-E and -F, and strands 15 and 16. 
The orientation of the structures is the same as that in b. (d) structural 
comparison between nmDA-bound Glun2D (wheat and light grey) and  
l-glutamate-bound Glun2A (green) in stereoview. The superposition 
shows a similarity in orientation of hinge loops (arrows) between Glun2A 
and Glun2D. The root mean square deviation of superposition is 1.10 Å 
over 263 Cα positions. Disulphide bonds are omitted for clarity in c and d.
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constants (fast and slow) describing deactivation time course 
observed in the GluN1/GluN2D receptors is largely absent in the 
GluN1/GluN2A receptors (Table 1). Furthermore, the conformation 
of the GluN2D LBD structure is dependent on the agonist, differ-
ing when in complex with l-glutamate compared with d-glutamate, 
l-aspartate and NMDA. These observations imply that the ligands 
induce conformational changes within the GluN2D LBD, which may 
be the contributing factors in the regulation of the deactivation time 
course following agonist removal. To test this hypothesis, we meas-
ured the deactivation time courses of d- and l-glutamate-induced 
currents from chimeric NMDA receptors (Fig. 6). We chose to make 
chimeric receptors between GluN2A and GluN2D because GluN1/
GluN2A receptors deactivate more rapidly than GluN1/GluN2D 
receptors when activated by l-glutamate, providing the greatest 
difference in deactivation time course among all GluN2 subunits. 
In addition, crystal structures of the l-glutamate-bound GluN2A 
LBD have been previously described7, allowing design of chimeric 
receptors that minimally perturb the overall subunit architecture.
We first evaluated GluN2A–(GluN2D–D1D2) chimeric recep-
tors, which are the GluN2A subunits engineered to contain the 
entire LBD (that is, both D1 and D2 regions) of GluN2D. The 
GluN2A–(GluN2D–D1D2) receptors had a slower deactivation 
time course for l-glutamate (τFast = 170 ± 35 ms; τSlow = 740 ± 230 ms; 
n = 5) compared with wild-type GluN1/GluN2A (n = 21; Table 2). 
By contrast, the GluN2A–(GluN2D–D1D2) receptors had a similar 
time course for d-glutamate (τFast = 12 ± 1.9 ms; τSlow = 200 ± 49 ms; 
n = 5; Supplementary Table S3) as the wild-type GluN1/GluN2A 
receptors (τFast = 16 ± 1.3 ms; τSlow = 280 ± 130 ms; n = 7; Table 1). This 
observation demonstrates that the full LBD can uniquely influence 
the deactivation time course of GluN1/GluN2D receptors activated 
by l-glutamate but not d-glutamate. Of note, the GluN2D LBD did 
not fully interconvert the deactivation time course of GluN2A to 
that of GluN2D, consistent with the recently suggested role of the 
ATD in the control of deactivation20,21.
We subsequently conducted voltage-clamp recordings of chi-
meric receptors containing the individual D1 or D2 domains of the 
GluN2D LBD to dissect the potential contributions of the D1 and 
D2 regions to the change in l-glutamate deactivation time course. 
The GluN1/GluN2A–(GluN2D–D1) receptors, which contain the 
D1 domain of the GluN2D subunit, had slower deactivation time 
Figure 4 | Conformational variability at the clamshell hinge. (a) stereoview of the overall structures of the Glun2D LBD in complex with various ligands. 
The structural superposition reveals a distinct conformation of hinge loops (coloured loops) between the l-glutamate-bound form (cyan) and all the other 
forms (l-aspartate, yellow; d-glutamate, magenta; and nmDA, green). Ligands are shown as sticks. (b, c) Fo-Fc omits electron density of the hinge loop 
contoured at 2.8σ for the l-aspartate- (b) and l-glutamate-bound (c) structures. The residues are well ordered, except for a portion of Lys779, as shown 
by a breakage at the electron density map. (d, e) Different modes of interactions between the hinge loop and helices-E-F or helix-H in the l-aspartate-
bound (d) and l-glutamate-bound (e) structures in stereoview. The loop that contains Leu690 in the l-aspartate-bound structure (loop-D) and helix-D 
are disordered in the l-glutamate-bound structure. Ligands are shown as spheres. Residues on the hinge loops are coloured as yellow and cyan for l-
aspartate-bound and l-glutamate-bound structures, respectively. Residues proximal to the hinge loop are in white.
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course compared with the wild-type GluN1/GluN2A receptors 
(τFast = 98 ± 4.7 ms; τSlow = 410 ± 56 ms; n = 5; Table 2). The GluN2A–
(GluN2D–D2) receptor, which includes the GluN2D hinge loop 
region, also deactivated more slowly than wild-type GluN1/
GluN2A following the removal of l-glutamate (τFast = 110 ± 5.6 ms; 
τSlow = 660 ± 83 ms; n = 7). These data suggest that both the lobes 
of the LBD influence the deactivation time course of the GluN1/
GluN2D NMDA receptors.
Because the deactivation time course is related both to agonist 
unbinding and channel gating, we measured the l-glutamate EC50 
and estimated the open probability (POpen) using the rate of onset 
of MK-801 block following activation by l-glutamate and glycine38  
for chimeric NMDA receptors expressed in Xenopus oocytes. The 
estimated POpen values of the chimeric receptors were not signifi-
cantly different from that of the wild-type GluN2A (Supplementary 
Table S4), consistent with previous studies showing that the ATD is 
the primary determinant of the POpen of both GluN2A and GluN2D21. 
Both GluN2A–(GluN2D–D1) and GluN2A–(GluN2D–D2) had 
lower EC50 values for l-glutamate (EC50 = 0.68 ± 0.20; n = 4 and 
EC50 = 1.2 ± 0.20; n = 4, respectively) compared with GluN2A (Table 2). 
The potency of l-glutamate in the GluN2A–(GluN2D–D1D2) 
receptors (EC50 = 0.44 ± 0.082; n = 6) was identical to the wild-type 
GluN2D NMDA receptors (EC50 = 0.48 ± 0.078; n = 4), in contrast to 
deactivation time course, which is shifted only partially towards the 
value for wild-type GluN2A (Table 2).
The crystal structures show that the hinge within D2 of the LBD 
is the most structurally divergent region between the GluN2A and 
GluN2D LBDs, and is subjected to ligand-specific conformational 
changes. Using the GluN2A and GluN2D LBD structures as a guide, 
we identified two residues that varied between the GluN2A and 
GluN2D hinge regions. We evaluated whether we could transfer the 
slower time course of GluN2A–(GluN2D–D2) chimeric receptors 
to GluN2A receptors by exchanging individual residues within the 
structurally divergent hinge. Consistent with data from chimeric 
receptors, GluN2A-Y754K deactivated with a slower time course 
for l-glutamate (τFast = 110 ± 7.5 ms; τSlow = 950 ± 150 ms; n = 20; 
Table 2) and a slower deactivation time course for d-glutamate 
(τFast = 27 ± 1.4 ms; τSlow = 400 ± 130 ms; n = 8; Supplementary Table 
S5) compared with wild-type GluN2A. By contrast, exchanging 
both divergent residues in GluN2A did not significantly alter deac-
tivation time course (Table 2). Furthermore, the reverse experiment 
of moving the divergent residues in the GluN2A hinge region into 
GluN2D does not accelerate the deactivation; rather, it either has 
no effect or causes a significant lengthening of deactivation com-
pared with wild-type GluN2D (Table 2, Supplementary Table S5). 
These data show that the structurally divergent region, while capable 
of influencing deactivation, by itself cannot fully account for differ-
ences in deactivation rates observed in the GluN2A–(GluN2D–D2) 
chimeric receptors. This is consistent with the idea that the struc-
tural determinants of deactivation within these multimeric recep-
tors are complex, and may involve parts of the LBD outside the 
hinge region and perhaps in parts of receptor not included in the 
crystal structures studied here.
Discussion
One of the remarkable characteristics of NMDA receptors is the 
large difference in the deactivation rate among NMDA receptors 
containing different GluN2 subunits, with the most prominent 
difference occurring between GluN2A- and GluN2D-containing 
Figure 5 | Agonist-binding site of GluN2D and determinants for NMDA 
specificity. (a–d) All of the ligands tested in this study bind in the 
interdomain cleft between domains D1 and D2. shown here are stereoviews 
of the ligand-binding site of Glun2D in complex with l-glutamate  
(a; cyan), d-glutamate (b; magenta), l-aspartate (c; yellow) and nmDA  
(d; green). A water molecule (W) present in the l-glutamate-, d-glutamate- 
and l-aspartate-binding pocket is represented by a red sphere. shown on 
the right hand side of a–d in blue mesh are Fo − Fc omit difference Fourier 
maps for the ligands and the attached water molecule contoured at 4σ. 
(e) structures of the Glun2D LBD (grey) and GluA2 LBD (PDB code 1FTJ; 
yellow) are superimposed to one another to show unfavourable placement 
of nmDA molecule (green) in non-nmDA receptors. Corresponding 
residues of Glun2D Tyr755, Asp756 and Val759 in GluA2 are Leu704, 
Glu705 and met708 (yellow), respectively. The placement of the N-
methyl group of nmDA is favoured in the Glun2 subunit because of the 
hydrophobic environment created by Tyr755 and Val759, and because 
of the location of the Asp756 side chain away from the pocket. In AmPA 
receptors, the equivalent residue to Asp756 is glutamate (Glu705), 
the longer side chain of which would collide with the N-methyl group. 
The binding is also disfavoured because of replacement of Val759 with 
methionine, which makes the binding pocket less hydrophobic.
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receptors. An exceptionally slow rate of deactivation is a hallmark 
of the GluN1/GluN2D NMDA receptors and may be important for 
early brain development. Here we show that l-glutamate, but not 
other linear agonists, produces both a unique conformation and 
slow deactivation in GluN1/GluN2D NMDA receptors. The rela-
tionship between EC50 values and deactivation rates involves gat-
ing, and thus is complex39–42. For GluN1/GluN2D receptors (but not 
GluN1/GluN2A receptors), the relative contribution of the fast and 
slow exponential components describing deactivation varies widely. 
Furthermore, data from the chimeric GluN1/GluN2A receptors 
containing the GluN2D LBD suggest that deactivation is dependent 
on ligand stereochemistry.
Variation in ligand structure has long been known to alter deac-
tivation rates of ligand-gated ion channels, first being described in 
studies of the muscle nicotinic receptor. For example, the deactiva-
tion time course of end-plate currents is accelerated by the release 
of the false neurotransmitter acetylmonoethylcholine, which shows 
brief channel open time compared with acetylcholine43. Similar 
experiments with d-glutamate in cultured hippocampal neurons 
also illustrate the dependence of deactivation rate on the activating 
ligand44. Furthermore, multiple studies on native and recombinant 
NMDA receptors have described an agonist dependence of deactiva-
tion rate and single-channel properties, including mean open time 
and shut-time durations4,19,45,46. However, what seem unique about 
GluN2D are the marked structural changes in the isolated GluN2D 
LBD when bound to l-glutamate compared with other ligands and 
the GluN2A LBD. The crystal structure of a full-length tetrameric 
AMPA receptor has established that the isolated LBDs accurately 
represent the extracellular domains in the intact receptors5. There-
fore, although there may be a minor difference in the orientation 
of the hinge residues between full-length GluN1/GluN2D recep-
tors and the isolated GluN2D LBD, the divergence of this region for 
l-glutamate compared with other agonists suggests that l-glutamate 
induces unique intraprotein interactions within GluN2D compared 
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Figure 6 | Assessment of molecular correlates of GluN2D deactivation. (a) Cartoons of the wild-type and chimeric receptors are given, with Glun2A in 
green and Glun2D in wheat. (b) l-glutamate (1 mm) was applied rapidly to transfected HEK cells for 1 s (grey bars); 0.05-mm glycine was present in all 
solutions. Inserting portions or the full Glun2D–D1D2 LBD increased the fast and slow time constants describing the deactivation time course compared 
with the time constants of Glun1/Glun2A. The horizontal scale bar represents 2 s for all traces, and the vertical scale bar represents ~200 pA for all 
traces. (c) normalized current traces of the deactivation time courses of Glun2A and chimeric receptors following removal of l-glutamate. (d) normalized 
current traces of Glun2A and chimeric receptors following the removal of d-glutamate. The deactivation time course following removal of d-glutamate 
did not significantly lengthen for any chimeric receptor. (e) The slow deactivation time constant (τslow) of Glun2A and the chimeric receptors is given 
for l-glutamate (white bars) and d-glutamate (grey bars). Bars are given in mean ± s.e.m. *P < 0.05 when compared with the deactivation time course of 
Glun1/Glun2A activated by l-glutamate and analysed by one-way AnoVA with Tukey’s post hoc test.
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with other linear ligands bound to GluN2D or l-glutamate bound 
to GluN2A.
Accumulating evidence indicates that multiple regions of the 
GluN2 subunits are involved in regulation of the deactivation time 
course. Recent studies have shown that the ATD and the 16-amino-
acid linker between the ATD and LBD (ATD–D1 linker) control 
the deactivation rate and open probability. Substitutions of the ATD 
or ATD–D1 linker from GluN2A with that from GluN2D result in 
approximately a sixfold or twofold increase in deactivation time 
course, respectively20,21. In the current study, we show that the sub-
stitution of the LBD of GluN2A with that of GluN2D also slows the 
deactivation time course for l-glutamate to a similar degree as the 
ATD substitution (Table 1). Evaluation of individual domains D1 
and D2, as well as individual residues in the hinge region, suggests 
that the structural determinants of deactivation within the LBD 
are broadly distributed. Thus, in addition to the ATD, we propose 
that the LBD is also an important determinant of the deactivation 
process for l-glutamate33,47. Remarkably, the GluN2D LBD does not 
control the deactivation time course of d-glutamate-induced cur-
rents, indicating that the LBD of GluN2D may distinctively sense 
l-glutamate from other linear ligands.
Previous studies of glutamate receptor LBDs have indicated 
that opening and closing of the bilobed clamshell structure on 
ligand binding and unbinding translate into the major physical 
driving force for gating of ion channel pores7,48,49. The crystallo-
graphic analyses conducted here show that the extent of domain 
closure between D1 and D2 in the GluN2D LBD structures is nearly 
identical when complexed with the four linear ligands (l- and d-
glutamate, l-aspartate and NMDA). However, a substantial differ-
ence in conformation is observed in the region containing the hinge 
loop at the backside of the ligand-binding site, including helix-D, 
-E, and -F, and loop-D in D2 between the structures in complex 
with l-glutamate and other ligands. The conformation of the hinge 
loop in the l-glutamate-bound form is such that the residues can no 
longer interact with helix-D and loop-D, making them highly disor-
dered or flexible. It is plausible that this change in helix-D and loop-
D orientation can affect gating properties (and thus deactivation 
time course) because they are in proximity to the region at which 
transmembrane helices are tethered in the intact receptors.
The hinge region may also be important for sensing l-glutamate, 
even though it is not directly involved in binding, because deac-
tivation rates of d-glutamate-induced currents are not changed in 
the chimeric or mutant receptors for which this region is altered. 
In the GluN1 subunit, a similar site is important for discriminating 
partial agonists from full agonists10. The equivalent structural motifs 
involving the hinge loop (strand 14 in GluN1) and helix-E and -F 
(helix-F and -G in GluN1) in GluN1 LBD have conformational vari-
ability between the glycine-bound and partial agonist-bound forms, 
thereby serving as a sensor for discriminating types of ligands and 
regulating the open probability of the ion channel.
Methods
Molecular biology. cDNAs for the recombinant rat wild-type NMDA recep-
tor subunits GluN1-1a (GenBank U11418, U08261; hereafter GluN1), GluN2A 
(GenBank D13211) and GluN2D (GenBank L31611) were used for recordings. 
Constructs encoding chimeric rat GluN2A and GluN2D proteins for GluN2A–
(GluN2D–D1D2), GluN2A–(GluN2D–D1) GluN2A–(GluN2D–D2) and point 
mutants were developed, as previously described21,47. All receptors were verified 
by DNA sequencing and were subcloned into the pCI-neo vector, except GluN2A 
(wild type; pcDNA1/AMP vector). Amino-acid composition of chimeric receptors 
is given in Supplementary Table S6.
Two-electrode voltage-clamp recordings. Preparation and injection of antisense 
RNAs into Xenopus laevis oocytes as well as all two-electrode voltage-clamp 
recordings (VHold =  − 30 to  − 60 mV) were performed, as previously described50. 
Oocytes were stored at 15 °C in Barth’s culture bath containing 88-mM NaCl, 
5-mM Tris-HCl, 2.4-mM NaHCO3, 1-mM KCl, 0.82-mM MgSO4, 0.41-mM CaCl2 
and 0.33-mM Ca(NO3)2 at pH 7.4. Oocytes were injected with 5–10 ng of antisense 
RNAs synthesized in vitro from linearized template cDNA at a ratio of 1 GluN1 
subunit to 2 GluN2 subunits. Recordings were made 2–4 days before injection at 
23 °C (room temperature). The external bath solution contained 90-mM NaCl, 
10-mM HEPES, 1-mM KCl, 0.5-mM BaCl2 and 0.01-mM EDTA at pH 7.4. Voltage 
electrodes were filled with 0.3-M KCl, and current electrodes contained 3-M KCl. 
Voltage and data acquisition were controlled with a two-electrode voltage-clamp 
amplifier (OC725, Warner Instruments), and an eight-modular valve positioner 
(Digital MVP Valve)-controlled solution exchange. Recording solutions were 
prepared in external bath solution and contained glycine (30 µM) and glutamate 
(0.1–100 µM). MK-801 (200 nM; Sigma-Aldrich) was prepared in bath solution 
containing glutamate (100 µM) and glycine (30 µM).
Cell culture. Human embryonic kidney-293 cell lines (CRL 1573; ATCC; here-
after HEK cells) were plated on 5-mm diameter glass coverslips (Warner Instru-
ments) coated in 100-µg/ml poly-d-lysine and were maintained in 5% humidified 
CO2 at 37 °C in DMEM (cat. no. 11960; Invitrogen) supplemented with 10% fetal 
bovine serum, 10 U per ml penicillin and 10 µg per ml streptomycin. HEK cells 
were transiently transfected using Fugene6 (Roche Diagnostics) with cDNA 
encoding green fluorescent protein, GluN1, and GluN2A, GluN2D, or a mutant 
or chimeric GluN2 subunit at a ratio of 1:1:1 for 0.5 µg per well total cDNA21. 
Table 2 | GluN2A/2D chimeric and mutant receptors activated by l-glutamate.
Receptor Fast (ms) Slow (ms) W (ms) Fast (%) n EC50
Chimeric receptors
 Glun2A WT 39 ± 1.8 360 ± 53 54 ± 3.5 89 ± 4.4 21 4.5 ± 0.42
 Glun2A–(Glun2D–D1) 98 ± 4.7* 410 ± 56 150 ± 11 80 ± 7.1 5 0.68 ± 0.20**
 Glun2A–(Glun2D–D2) 110 ± 5.6* 660 ± 83* 160 ± 4.5* 88 ± 2.7 7 1.2 ± 0.2**
 Glun2A–(Glun2D–D1D2) 170 ± 35* 740 ± 230* 280 ± 42* 72 ± 8.0 5 0.44 ± 0.082**
 Glun2D WT 930 ± 100* 3200 ± 240* 2300 ± 96* 37 ± 4.3* 30 0.48
Point mutants
 Glun2A WT 38 ± 1.7 330 ± 50 54 ± 3.2 88 ± 4.0 21 —
 Glun2A-Y754K 110 ± 7.5 + 950 ± 150 + 170 ± 18 + 91 ± 1.3 20 —
 Glun2A-Y754K, I755V 32 ± 1.5 370 ± 60 55 ± 4.6 90 ± 2.6 12 —
 Glun2D WT 930 ± 100 3200 ± 240. 2300 ± 96 37 ± 4.3 30 —
 Glun2D-K779Y 670 ± 150 2900 ± 260 2200 ± 94 32 ± 6.5 9 —
 Glun2D-V780I 440 ± 170 4800 ± 630 4100 ± 630^ 17 ± 4.1 5 —
 Glun2D-K779Y, V780I 1100 ± 170 4400 ± 400 3300 ± 190^ 34 ± 6.6 5 —
AnoVA, analysis of variance; WT, wild type.
τFast, τslow, τW, fast (%) and EC50 values are shown as mean ± s.e.m., and n is the number of cells for deactivation measurements; EC50 values were determined in four to six oocytes for each receptor. All 
data are given to two significant figures. *P < 0.05 when compared with the deactivation time course of Glun1/Glun2A activated by l-glutamate and analyzed by one-way AnoVA with Tukey’s post hoc 
test. **P < 0.05 when log(EC50) is compared with the log(EC50) of l-glutamate for Glun1/Glun2A and analyzed by one-way AnoVA with Tukey’s post hoc test (see methods).  + P < 0.05 when compared 
with the deactivation time course of Glun1/Glun2A activated by l-glutamate and analyzed by one-way AnoVA with Tukey’s post hoc test. ^P < 0.05 when compared with the deactivation time course of 
Glun1/Glun2D activated by l-glutamate and analyzed by one-way AnoVA with Tukey’s post hoc test.
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Following transfection, cells were incubated in media supplemented with NMDA 
receptor antagonists d,l-2-amino-5-phosphonovalerate (200 µM) and 7-chloro-
kynurenic acid (200 µM).
Whole-cell voltage-clamp recordings. Voltage-clamp current recordings 
(VHold =  − 60 mV) were conducted on HEK cells using an Axopatch 200B amplifier 
(Molecular Devices) and digitized by Axon pClamp10 software. Recordings were 
filtered at 8 kHz using an eight-pole Bessel filter ( − 3 dB; Frequency Devices) 
and digitized at 40 kHz. Thin-walled borosilicate glass (Warner Instruments, 
1.5 mm/1.12 mm outer diametre/inner diametre, cat. no. TW-150F-4) was used 
to form recording micropipettes, which were filled with an internal solution 
containing 110-mM d-gluconate, 110-mM CsOH, 30-mM CsCl, 5-mM HEPES, 
4-mM NaCl, 0.5-mM CaCl2, 2-mM MgCl2, 5-mM BAPTA, 2-mM NaATP and 0.3 
NaGTP (pH 7.35). Cells were bathed at 23 °C in external solution that contained 
150-mM NaCl, 10-mM HEPES, 30-mM d-mannitol, 3-mM KCl, 0.5-mM CaCl2 
and 0.01-mM EDTA at pH 8.0. Macroscopic currents were evoked from cells 
lifted into the path of a two-barrel theta tube by application of 0.05-mM glycine, 
followed by 1-s pulses of agonist solutions containing 0.05-mM glycine plus 
0.1–1 mM of l-glutamate or other GluN2 ligands, and returned to the initial 0.05-
mM glycine application for 3–25 s. In paired-pulse experiments, GluN1/GluN2D 
receptors were activated by 2-ms or 4-s pulses of 1-mM l-glutamate and 0.05-
mM glycine, followed by a second pulse applied 2–10 s after the removal of the 
first pulse for 2 ms or 4 s. Rapid solution exchange for macroscopic recordings 
was accomplished with a theta pipette controlled by a piezoelectric translator 
(Burleigh Instruments). Whole-cell 10–90% solution exchange times were ~4 ms 
and were determined, as previously described51, and 10–90% open-tip solution 
exchange times were under 0.5 ms. Between 5 and 10 sweeps were recorded for 
each condition.
Data analysis. For each macroscopic current condition, the current response 
waveforms recorded under voltage clamp were aligned on the point of steepest rise 
and averaged following subtraction of the preapplication baseline. Current ampli-
tude, 10–90% rise time and deactivation time constant were determined. Relative 
maximum response was determined by expressing the response of a maximally 
effective concentration of a given agonist as a percentage of the response to 1-mM 
l-glutamate recorded in the same cell. The deactivation time constant was fit using 
the following equation: 
Response Amp time Amp timeF F S S= − + −ast ast low lowexp( / ) exp( / )t t , 
where τFast is the fast deactivation time constant, τSlow is the slow deactivation time 
constant, AmpFast is the amplitude of the fast deactivation component, AmpSlow is 
the amplitude of the slow deactivation component and t = 0 is defined as the peak 
of the response at the moment deactivation is initiated. Weighted deactivation time 
constants (τW) were determined using the following equation: 
t tW = + ×
+ +
([ /( )] )
([ /(
Amp Amp Amp
Amp Amp
Fast S Fast
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AmpS Slow low)] )× t  
Relative POpen was estimated for chimeric receptors and point mutants by analyzing 
the time course for the onset of MK-801 inhibition, as previously described38. 
Briefly, the rate of onset of MK-801 inhibition was calculated using the following 
equation: 
BlockrateMK MK- -/801 8011= t , 
where τMK-801 block is the time constant for the onset of MK-801 block. τMK-801 block was 
calculated using the single-exponential equation 
Response Amp time steady-stateMK= − +exp( / )-t 801 ,
where Amp is the amplitude of the current response and steady state describes the 
steady-state current observed in the presence of incomplete MK801 block. Open 
probability (POpen) for the chimeric receptors and point mutants were calculated 
from the wild-type receptor open probability and the block rate of MK-801 using 
the following equation 
P POpen MUT Open MK WT MK MUT  ( ) ( / )- ( ) - ( )= t t801 801 , 
where GluN2A POpen was 0.48 and GluN2D POpen was 0.012, determined from 
single-channel data21. Concentration–response curves were fitted for each oocyte 
with the Hill equation 
Percent response EC A H= +100 1 50/( ( /[ ]) )n , 
where EC50 is the agonist concentration that produces a half-maximal effect, and nH 
is the Hill coefficient.
The responses of gating models were evaluated by numerical integration 
(Channelab, Synaptosoft) and assessment of the Q matrix13 to determine the  
(1)
(2)
(3)
(4)
(5)
(6)
deactivation time course and EC50 values as a function of the agonist dissociation 
rates (SCALCS, HJCFIT, kindly provided by Dr David Colquhoun, University  
College London). Three models were adapted as shown in Supplementary Figure 
S1 to simulate NMDA receptor responses.
Data are reported as mean ± s.e.m. and were evaluated statistically using one-
way ANOVA and Tukey’s post hoc test. Significance for all tests was set at P < 0.05. 
EC50 values are reported as mean ± s.e.m., but statistical analyses were performed 
on the log(EC50), as EC50 demonstrates a lognormal distribution52.
Protein purification and crystallization. The GluN2D LBD construct used in this 
structural study was defined as Asp424–Arg564 and Thr686–Asn827 connected by 
a Gly–Thr linker. The GluN2D LBD protein was expressed as a fusion protein to 
small ubiquitin-like modifier (SUMO) with the N-terminal hexa-histidine tag in 
Origami B (DE3) strain (Novagen) under T7 promoter in pET22b( + ) (Novagen). 
After growing cells to OD600 = 4 in a fermenter (BioFlo3000; New Brunswick) at 
37 °C, protein expression was induced by 0.5-mM IPTG at 15 °C for 36 h. The 
GluN2D LBD proteins were purified using Nickel-chelating Sepharose (GE Health-
care) and digested by ubiquitin ligase protease-1 to remove SUMO. The sample was 
further purified by a combination of Q-Sepharose, SP-Sepharose and Superdex200 
(GE Healthcare).
Structural studies. The purified GluN2D LBD proteins were concentrated to 
~5 mg ml − 1 and dialyzed against a buffer containing 10-mM Tris-HCl (pH 8),  
50-mM NaCl and 10 mM of d- and l-glutamate, l-aspartate or NMDA. All 
of the crystals were produced by vapour diffusion at 17 °C in hanging drops 
containing 2:1 protein to reservoir solution composed of 3.5- to 4.5-M sodium 
formate, 100-mM CAPS (pH 9–10) and 8–12% of 1,4-butanediol. The concentra-
tion of 1,4-butanediol was raised to 14% for cryoprotection of the crystals during 
data collection. The X-ray diffraction data was collected at X25, X26C and X29 
beamlines at the National Synchrotron Light Source at Brookhaven National 
Laboratory and processed using HKL2000. The structure of the l-glutamate-
bound form was determined by molecular replacement using an alanine chain of 
the GluN2A LBD structure (PDB code: 2A5S) as a molecular search probe and 
by using the program Phaser53. The GluN2D LBD structures in complex with 
l-aspartate, d-glutamate and NMDA were determined by molecular replacement 
using the structure of GluN2D LBD in complex with l-glutamate. Structural 
refinement and model building were performed with PHENIX54 and Coot55, 
respectively. 
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